Tag Archives | News Releases

IntegenX® Announces First State-Wide deployment of the RapidHIT® System with SmallPond™ at Arizona Department of Public Safety

Arizona Department of Public Safety (AZ-DPS) Crime Lab Superintendent Vince Figarelli presents first state-wide deployment of the RapidHIT System for real-time matching using a SmallPond database of DNA profiles.

PLEASANTON, California – May 13th, 2014 – IntegenX Inc., the market leader in Rapid Human DNA identification technology, today announced the first state-wide deployment of the RapidHIT System for real-time matching of DNA profiles. At the American Society of Crime Laboratory Directors Symposium in Scottsdale, AZ, Vince Figarelli, Crime Lab Superintendent at AZ-DPS, presented an overview of the Department’s state-wide deployment of the RapidHIT system.

Like many state crime laboratories across the country, AZ-DPS faces tight resource and budget constraints that limit the number of DNA samples that they can collect and process in a reasonable period of time. Their solution is to use the RapidHIT System in conjunction with the SmallPond database software to store and search over 350,000 DNA profiles. The simplicity of the system and the database interface has enabled state officials to train law enforcement officers to bring DNA samples to the instrument for processing and generate search results in hours rather than months. This puts law enforcement agencies squarely in control of which DNA cases need to be fast-tracked without impacting the important work being performed by laboratory personnel.

“The Arizona rapid DNA system can provide officers with investigative leads faster than ever before. In cases with appropriate samples, officers can perform the rapid DNA analysis and search the database in hopes of obtaining a preliminary identification of a suspect, rather than waiting weeks or months for laboratory results,” said Figarelli.

“The Arizona DPS deployment is a significant step for US Law Enforcement in preventing crimes with DNA,” commented Robert Schueren, President and Chief Executive Officer of IntegenX. “Generating real-time search results will provide tremendous safety benefits to the residents of Arizona”.

“SmallPond is committed to providing DNA databasing tools that enable law enforcement to maximize the potential of using DNA-based technologies to solve and prevent crimes in their communities”, commented Scott Rulong, President SmallPond, LLC.

The IntegenX RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile in less than two hours. With less than five minutes of hands-on time, an operator can generate up to seven complete DNA profiles. RapidHIT System DNA profiles are completely compatible with standard databases that contain previously generated profiles from reference and crime scene sources. Combining ease of use and rapid turnaround time for DNA human identification will have a high impact toward ensuring the safety of our communities.
About IntegenX Inc.

IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing for forensics and law enforcement applications. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.
About SmallPond

SmallPond, LLC, headquartered in Fishers, Indiana, is a leading developer of DNA-Profile matching technology that enables users (e.g., law enforcement or government agencies) to maintain their own private database of STR DNA-Profile information and provides for real-time matching of DNA Profiles. This product performs very much like the national CODIS database and can be used as a resource to various agencies by enabling matching on DNA-Profiles that may not be eligible for promotion to CODIS. To learn more about SmallPond, please go to www.smallpondllc.com or contact Eric White, Global Sales Manager at eric@smallpondllc.com or 317-570-4900.

###

IntegenX
David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
Tel +1 925 701 3400

Morpho Partners with IntegenX to Offer Rapid DNA Identification Technology

This is a press release from Morpho (Safran). For more information, visit Morpho and Safran at www.morpho.com  and   www.safran-group.com.

Paris, France / Pleasanton, CA, USA – April 29, 2014 – Morpho (Safran), the world leader in biometric solutions, is joining with IntegenX, the market leader in rapid DNA technology, to offer DNA identification solutions providing DNA profiles in approximately 90 minutes. Morpho will partner with IntegenX to market its RapidHIT® System to law enforcement and government agencies in select countries around the world.

Based on a breakthrough technology, the RapidHIT is a fully automated system that generates DNA profiles from reference samples. It can be used in laboratories, police stations or directly at the crime scene. The RapidHIT System is the first rapid DNA technology to use an FBI-approved chemistry, enabling the upload of DNA profiles to the National DNA Index System (NDIS)*.

For the past three decades, Morpho has been providing criminal identification solutions to law enforcement and government agencies around the world. Under this partnership, Morpho will leverage its world leadership in biometrics (Automated Biometric Identification Systems and booking stations) and its global presence to offer DNA solutions and support services. By adding DNA to its biometric technology portfolio, Morpho will deliver powerful solutions capable of accelerating investigations, particularly during the custody period.

“IntegenX is committed to bringing Rapid DNA testing to the forefront of our communities” stated Robert Schueren, President, Chief Executive Officer of IntegenX. “We are excited by the capabilities brought forward through our partnership with Morpho”.

“Our customers around the world look to us for the most innovative and efficient criminal investigation solutions,” commented Philippe Petitcolin, Chairman and Chief Executive Officer of Morpho. “We are proud to collaborate with IntegenX to introduce rapid DNA identification to speed up crime solving in the field.”

* NDIS: Contains the DNA profiles contributed by federal, state, and local participating forensic
laboratories.

About Morpho
Morpho, a high-technology company of Safran, is a global leader in security solutions. The company employs more than 8,400 people in 40 countries and reported revenues of 1.5 billion euros in 2013. Morpho’s unique expertise lies in providing cutting edge security solutions for government identity, public security, critical infrastructure, transportation and business markets. Morpho is the world leader in multibiometric identification technologies, biometric identity documents, Automated Biometric Identification Systems (ABIS) and Explosives Detection Systems (EDS). It is one of the leading suppliers of SIM cards, smart cards, trace detection equipment and gaming terminals. With systems operating in more than 100 countries, Morpho’s solutions simplify and secure the lives of people around the world.

About IntegenX
IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing for forensics and law enforcement applications. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###
Contacts:

Morpho (Safran)
Christelle Kinkead
Media Relations Manager
11 boulevard Gallieni
92130 Issy-les-Moulineaux
France
Tel +33 (0)1 58 11 87 44
christelle.kinkead@morpho.com
www.morpho.com

IntegenX
David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
Tel +1 925 701 3400

IntegenX to Support Forensic DNA Day on Capitol Hill

PLEASANTON, California – April 22 2014 – IntegenX Inc., the market leader in Rapid Human DNA identification, announced today that it will be attending the Forensic DNA Day event Tuesday April 29th from 1:00 PM to 3:00 PM in the Rayburn House Office Building on Capitol Hill in Washington, DC. The event is sponsored by the Rape, Abuse, Incest National Network (RAINN) and the National Center for Victims of Crime (NCVC). The event will include brief remarks from Debbie Smith, Elizabeth Smart, and a few key Members of Congress, providing an opportunity to showcase forensic DNA technologies for members of Congress and legislative staff who play a key role in determining national policy and funding priorities.

IntegenX will be showcasing the company’s RapidHIT® System, an automated instrument that enables forensic experts to generate DNA profiles for law enforcement professionals in less than two hours, where current processes take months or years. RapidHIT is the first fully automated sample-to-answer system for DNA profile analysis, applicable to police booking station and border checkpoints, to help stop violent crime, human trafficking and fraudulent asylum requests. Now samples processed using IntegenX GlobalFiler® Express cartridges can be uploaded to the FBI’s Combined DNA Index System (CODIS).

“We look forward to demonstrating to attendees how the RapidHIT System enables Law Enforcement professionals to bring criminals to justice faster and ultimately keep their communities safer,” commented Robert A. Schueren, President, Chief Executive Officer, IntegenX.

About IntegenX

IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing for forensics and law enforcement applications. For more information, please visit www.integenx.com.

IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###
Contact:
David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400

IntegenX Announces ISO 9001:2008 Certification

IntegenX® has been awarded the ISO 9001:2008 certification for the design, development, manufacture, and distribution of automated DNA identification systems

PLEASANTON, California – March 31, 2014 – IntegenX Inc., the market leader in Rapid Human DNA identification, announced today that it has earned ISO 9001:2008 certification for its quality management system for the design, development, manufacture and distribution of automated DNA identification systems. IntegenX manufactures the RapidHIT® System for human identification and is the first company in the rapid DNA market to achieve such a standard.

“Meeting a high quality standard is a priority for everyone at IntegenX,” said David V. Smith, Chief Operating Officer. “Fulfilling the stringent requirements of the ISO 9001:2008 standard is part of our effort to deliver total customer satisfaction as it relates to quality.”

ISO 9001:2008 is a quality management system standard developed by the International Organization for Standardization, an association of governmental and nongovernmental organizations from 163 countries that develops international standards. The ISO 9001:2008 standard is used to certify quality management systems that focus on customer satisfaction, continuous improvement, active involvement of senior management and employees, and the adoption of a process approach. Certification under ISO 9001:2008 implies customers will benefit from products that are robust and reliable, readily available meeting international regulatory standards.

“Earning certification is a significant accomplishment by our employees’, reflecting their commitment and hard work,” commented Robert A. Schueren, President, Chief Executive Officer. “Our customers expect exceptional products that also adhere to the highest standards of quality and performance.”

About IntegenX

IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing for forensics and law enforcement applications. For more information, please visit www.integenx.com.

IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###
Contact:
David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400

IntegenX Announces Approval to Upload DNA Profiles from the RapidHIT® System to the National Database

The RapidHIT System is the first rapid DNA technology that uses FBI-approved GlobalFiler® Express chemistry, enabling the upload of DNA profiles to the National DNA Index System (NDIS)

PLEASANTON, California – March 13, 2014 – IntegenX Inc., the market leader in Rapid Human DNA identification, has met the FBI guidelines to upload data to the NDIS system, after forensic review, of known arrestee and convicted offender DNA profiles, as well as casework known samples, generated with the RapidHIT System using Life Technologies GlobalFiler Express kits from Thermo Fisher Scientific.

The RapidHIT GlobalFiler Express cartridges contain Life Technologies NDIS-approved GlobalFiler Express Kit, which has all DNA markers commonly used in most international databases. NDIS is considered one part of Combined DNA Index System (CODIS), the national level containing the DNA profiles contributed by federal, state, and local participating forensic laboratories. CODIS is the generic term used to describe the FBI’s program of support for criminal justice DNA databases as well as the software used to run these databases.

“Having the ability to upload a profile into the national database from a Rapid DNA system provides laboratories with an excellent option for turning results around quickly” commented Gray Amick, Ph.D., DNA Technical Leader at Richland County Sheriff’s Department. “In our continued quest to reduce time to generating results, the RapidHIT System provides a great option.”

“For the first time ever, an accredited forensic laboratory can upload a DNA profile from a Rapid DNA system in less than two hours, into our national database,” commented Robert A. Schueren, president, chief executive officer, IntegenX. “We’re thrilled to be the first and only company to achieve such a milestone”.

“The GlobalFiler Express chemistry has proven to be a transformative solution for forensic labs since first introduced in 2012 and approved by the FBI a year later,” said Nadia Altomare, vice president and general manager, Human Identification, for Thermo Fisher Scientific. “The speed and superior quality of data obtained by our solution expedites comparison of DNA profiles to help solve and prevent crimes faster.”

With less than five minutes of hands-on time, the RapidHIT system enables buccal swabs collected from known arrestees and convicted offenders, as well as casework known samples to be analyzed in less than two hours, compared to weeks or months with conventional laboratory techniques, dramatically improving efficiency of forensic laboratories. This improved efficiency will allow laboratories to spend more time reducing backlog and processing other forensic samples. The innovative design of the Life Technologies GlobalFiler Express cartridges allows users to process between one and seven samples in a single run, offering further savings to forensic laboratories.

RapidHIT System DNA profiles are completely compatible with standard databases that contain previously generated profiles from buccal swabs and crime scene sources. Combining ease of use and rapid turnaround time for DNA human identification will have a high impact toward ensuring the safety of our communities.

More information about the ability to utilize Rapid DNA technology with NDIS may be found at http://www.fbi.gov/about-us/lab/biometric-analysis/codis/codis-and-ndis-fact-sheet

About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing for forensics and law enforcement applications. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###
Contact:
David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400

IntegenX Launches New GlobalFiler® Express Cartridges for RapidHIT® System at the American Academy of Forensic Sciences (AAFS) Meeting

IntegenX has completed the Developmental Validation of GlobalFiler Express reagents from Life Technologies on the RapidHIT System in accordance with SWGDAM guidelines

PLEASANTON, California – February 18, 2014 – IntegenX Inc., the market leader in Rapid Human DNA identification technology, today announced the launch of GlobalFiler® Express cartridges for the RapidHIT™ System, providing DNA profiles with 24-loci in less than two hours with less than five minutes hands-on time. The RapidHIT GlobalFiler Express cartridges contain Life Technologies’ NDIS-approved GlobalFiler Express Kit which has all DNA markers commonly used in most international databases, including all markers recommended for inclusion by the CODIS Core Loci Working Group. The RapidHIT GlobalFiler Express cartridges feature a flexible design, allowing operators to run from one to seven samples in a single run, as well as a room temperature cartridge storage protocol.

IntegenX completed the Developmental Validation of the GlobalFiler Express cartridges with the RapidHIT System for buccal swabs with a highly successful CODIS profile generation rate. Completion of Scientific Working Group for DNA Analysis Methods (SWGDAM) Developmental Validation is a key milestone necessary for the commercialization of human DNA identification systems in forensics, law enforcement, defense, homeland security, and intelligence community applications: the RapidHIT is the only Rapid DNA System to have met such a milestone.

In addition to Developmental Validation data for buccal swabs, IntegenX has generated data demonstrating the RapidHIT System readily analyzes samples routinely recovered from crime scenes, such as blood, saliva, and semen. These applications dramatically expand the utility of the RapidHIT System and provide a fast DNA-based crime scene investigation and rapid lead identification capability for the law enforcement, defense, and intelligence communities worldwide. Data will be presented at the 66th Annual AAFS meeting, February 17-22, Seattle, Washington.

“The combination of the extremely high discrimination power of the large GlobalFiler Express multiplex and the capability of an expedited sample-to-answer with RapidHIT DNA technology should be a powerful tool to extend the utility of DNA typing both outside and within the laboratory,” said Bruce Budowle, Ph.D., executive director of the Institute of Applied Genetics at the University of North Texas Health Science Center (UNTHSC).

“We’re thrilled at the full commercial global launch of the RapidHIT GlobalFiler Express cartridges, and the new flexible format that allows operators to decide how many samples to include per run. The Developmental Validation of the GlobalFiler Express cartridges under SWGDAM guidelines is an important milestone. Offering Life Technologies’ most advanced NDIS-approved chemistry on the RapidHIT will be of great value to the US and worldwide forensic communities,” commented Robert Schueren, president and chief executive officer of IntegenX.

“The superior quality of the data obtained from GlobalFiler Express kits has proven to be a transformative solution for forensic labs,” said Nadia Altomare, vice president and general manager, Human Identification, for Thermo Fisher Scientific. “Our partnership with IntegenX brings together the industry’s most powerful chemistry and the leading rapid platform to help forensic laboratories and law enforcement agencies solve and prevent crimes.”

The IntegenX RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile in less than two hours. With less than five minutes of hands-on time, an operator can generate up to seven complete DNA profiles. RapidHIT System DNA profiles are completely compatible with standard databases that contain previously generated profiles from reference and crime scene sources. Combining ease of use and rapid turnaround time for DNA human identification will have a high impact toward ensuring the safety of our communities.

About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing for forensics and law enforcement applications. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###
Contact:
David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400

IntegenX RapidHIT™ to Star in November 6th episode of CSI: Crime Scene Investigation

Rapid DNA technology featured on CSI: Crime Scene Investigation is being utilized by forensic labs and law enforcement agencies worldwide

PLEASANTON, California – November 5, 2013 – IntegenX Inc., the leading developer of Rapid DNA human identification technology, today announced that the RapidHIT™ System will be starring in the November 6th episode of the long-running, forensic science-based television show CSI: Crime Scene Investigation. In episode 7, “Under A Cloud”, investigators will be racing against the clock to track a perpetrator, with the RapidHIT System as a critical technology to solve the crime.

CSI: Crime Scene Investigation writers make great efforts to research the latest cutting-edge forensic tools and technologies and ensure the show is representing the latest innovations. In episode 7, the RapidHIT System is deployed in a mobile crime scene vehicle, an actual scenario at a major law enforcement agency today. According to Sheila Thomas, Product Integration Specialist for the show, “Our technical advisors were contacted by various law enforcement agencies about the RapidHIT System. It’s simple to use, providing accurate results in 90 minutes. Without the RapidHIT System we could not have developed the storyline.”

While the story is fictional, the commercially available RapidHIT System is helping law enforcement agencies solve real crimes around the world. The RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile with less than five minutes of hands-on time. “We’re thrilled that the producers have chosen to premiere the RapidHIT on their show. It’s a testament to the system’s ability to combine ease of use with rapid turnaround time providing an invaluable impact toward solving crimes quickly, and ensuring the safety of communities worldwide”, commented Robert Schueren, President, Chief Executive Officer of IntegenX.

About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing, forensics, and biodefense applications. For more information, please visit www.integenx.com.

IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###

Contact:

David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400

IntegenX Presents Developmental Validation Data and End-User Evaluations of the RapidHIT System at the 24th International Symposium on Human Identification (ISHI24)

The RapidHIT System is the world’s first rapid DNA technology to complete developmental validation in accordance with SWGDAM guidelines, and achieve full global commercial launch

PLEASANTON, California – October 9, 2013 – IntegenX Inc., the leading developer of rapid human DNA identification technology, today announced that it presented the latest data on developmental validation of the RapidHIT™ System as outlined by SWGDAM (Scientific Working Group for DNA Analysis Methods) at the 24th International Symposium on Human Identification (ISHI 24) in Atlanta, GA, October 7–10, 2013.

The RapidHIT System is the first fully automated rapid human DNA identification system to complete developmental validation in accordance with SWGDAM guidelines. Completion of developmental validation is necessary for full commercialization of rapid DNA technologies for human identification in forensics, law enforcement, defense, homeland security, and intelligence community applications.

At the ISFG (International Society for Forensic Genetics) meeting in early September 2013, IntegenX provided previews of RapidHIT developmental validation data, including successful generation of CODIS profiles. Later in September, at the Biometric Consortium Conference, an inter-lab study conducted by a third-party group was presented, showing that the RapidHIT System outperformed other methods in categories including CODIS loci success rate, peak height ratio, and stutter.

“Overall, the RapidHIT System outperformed traditional capillary electrophoresis based methods in producing useable profile information on a first-pass basis. General observations included 100% concordance with known profiles, similar performance after two weeks of sample storage, and an absence of chamber-to-chamber or run-to-run contamination,” said Dr. Mitchell Holland, Director, Forensic Science, Pennsylvania State University.

At ISHI 24, IntegenX unveiled additional developmental validation data and shared evaluations of the RapidHIT System by end users at a workshop, “Making a Difference in Minutes – RapidHIT System Developmental Validation and End-User Evaluations for Rapid Human Identification.” The company also presented data on the ability of the system to rapidly generate DNA profiles from a variety of biological samples, such as blood and saliva, which are routinely recovered from crime scenes. Data on integration of a European STR assay on the system were also showcased.

“We continue to build upon the exceptional number of studies and outcomes with the RapidHIT System. The data continue to represent the level of performance any forensic lab has come to expect,” commented Robert Schueren, President and Chief Executive Officer of IntegenX.

These latest advances of the RapidHIT System dramatically expand its utility for use in crime scene investigation and rapid lead identification, enabling forensics and law enforcement personnel to quickly link a suspect’s DNA to a crime scene, or eliminate suspicion, while the suspect is still in custody.

The RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile in approximately 90 minutes. With less than five minutes of hands-on time, a user can generate up to five complete DNA profiles, as well as a positive and negative control. DNA profiles generated by the RapidHIT System are compatible with standard databases that contain previously generated profiles from reference and crime scene sources. Combining ease of use and rapid turnaround time for DNA results will have a high impact toward ensuring the safety of our communities.

About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing, forensics, and biodefense applications. For more information, please visit www.integenx.com.

IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###

Contact:

David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400

 

IntegenX to Present Significant Advances in Rapid DNA Technology at the 25th World Congress of the International Society of Forensic Genetics (ISFG)

The RapidHIT System is the world’s first rapid DNA technology to complete developmental validation in accordance with SWGDAM guidelines, and achieve full global commercial launch

PLEASANTON, California – September 2, 2013 – IntegenX Inc., the leading developer of rapid human DNA identification technology, today announced that it has completed developmental validation for the RapidHIT™ System, the first fully automated, fully integrated rapid human DNA identification system. Data will be presented at the 25thWorld Congress of the International Society of Forensic Genetics in Melbourne, Australia, September 2-7, 2013.

Completion of SWGDAM (Scientific Working Group for DNA Analysis Methods) developmental validation is a key milestone necessary for the full commercialization of DNA technologies for the purposes of human identification in forensics, law enforcement, defense, homeland security, and intelligence community applications. In addition to developmental validation data including highly successful CODIS profile generation, IntegenX will present data on the use of the RapidHIT System to analyze samples routinely recovered from crime scenes, such as blood and saliva. These applications dramatically expand the utility of the RapidHIT System for use in crime scene investigation and rapid lead identification by law enforcement, defense, and the intelligence community. The ability to rapidly generate DNA profiles on a variety of biological samples fundamentally changes the way investigations are conducted by enabling forensics and law enforcement personnel to quickly link a suspect’s DNA to a crime scene, or eliminate suspicion, all while the suspect is still in custody.

“The completion of a developmental validation study by the manufacturer is a critical important step toward establishing rapid DNA technology as reliable and robust. Rapid DNA technology will enable both forensic and law enforcement professionals to expand the use of DNA typing as a tool to solve crimes,” said Dr. Bruce Budowle, Professor, Executive Director of the Institute of Applied Genetics at the University of North Texas Health Science Center.

“We’re thrilled at the full commercial launch of the RapidHIT System, and the significant validation dataset we have been able to generate. We look forward to helping communities and governments throughout the world implement such a game changing technology,” commented Robert Schueren, President and Chief Executive Officer of IntegenX.

The IntegenX RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile in approximately 90 minutes. With less than five minutes of hands-on time, a user can generate up to five complete DNA profiles, as well as a positive and negative control. DNA profiles generated by the RapidHIT System are compatible with standard databases that contain previously generated profiles from reference and crime scene sources. Combining ease of use and rapid turnaround time for DNA results will have a high impact toward ensuring the safety of our communities.

About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing, forensics, and biodefense applications. For more information, please visit www.integenx.com.

IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

###

Contact:

David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400

 

IntegenX Names Robert A. Schueren Chief Executive Officer

PLEASANTON, Calif. – April 17, 2013 – IntegenX Inc., a privately held company and leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA ambient temperature stability and storage products, today announced the appointment of Robert A. Schueren as Chief Executive Officer.

Robert A. Schueren has nearly 30 years of commercial and operational experience, and has held leadership positions in life science companies for more than two decades. Most recently, he was Vice President and General Manager, Genomics, for Agilent Technologies. Prior to joining Agilent in 2010, he was the Global Head of Clinical Biomarkers and Operations and Deputy Global Head of Molecular Medicine Labs for Genentech, Inc., a company he joined in 2006. While at Genentech, Mr. Schueren held increasingly responsible positions including Senior Director, Development Sciences and Director Companion Diagnostics. Prior to Genentech, Mr. Schueren was the Executive Vice President and Chief Operating Officer of Arcturus Bioscience from 2003 to 2006. From 1997 to 2002, Mr. Schueren held leadership positions with Accumetrics. He also held commercial positions with Biosite Diagnostics and Gen-Probe, Inc.

“IntegenX is uniquely positioned to lead the revolution in how rapid DNA is applied—one that will transform law enforcement, intelligence and border control. For the first time, rapid DNA profiles will be included in the arsenal of actionable information used for human identification and to strengthen criminal and terrorist investigations.” said Mr. Schueren. “I am excited to participate in this new revolution and look forward to working with the IntegenX team as we drive the development of the significant new markets rapid DNA creates.”

Stevan Jovanovich, Ph.D., a founder and past President and CEO of IntegenX, will remain with the Company as Chief Technology Officer.

“We are delighted to have Bob join the company. His significant commercial and operations experience at companies such as Agilent and Genentech will prove invaluable as IntegenX commercializes its rapid human DNA identification system,” commented Dr. David Barker, Chairman of the Board of IntegenX. “The board is also very pleased that Stevan will assume the role of Chief Technology Officer, where he will continue to play a critical part in building the success of the Company.”

About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology, next-generation sequencing library preparation systems, and DNA/RNA ambient temperature stability and storage products. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing and forensics, next generation sequencing, and biodefense applications. The company’s expertise and extensive intellectual property includes its patented MOVe™ valve technology, patent-pending PrepX™ reagent kits for next generation sequencing library preparation, as well as a portfolio of patented DNA and RNA reagents including GenTegra™ for stabilization and storage of purified DNA and RNA, and GenPlate® for storage of blood samples. For more information, please visit www.integenx.com.

IntegenX, the IntegenX logo, PrepX, MOVe, GenTegra, GenPlate and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.

 

###

 

Contact:

David V. Smith
Chief Operating Officer
IntegenX Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588
925.701.3400